Aspire Biopharma Holdings Inc (ASBP)

Apr 15, 2026

Buzz Bomb Caffeine Partners with Interwest to Expand Retail Footprint - National Today

Apr 15, 2026

Apr 15, 2026

Aspire Biopharma's Buzz Bomb Caffeine Brand Partners with Interwest Brokerage - National Today

Apr 15, 2026

Apr 15, 2026

12 Health Care Stocks Moving In Wednesday's Intraday SessionAspire Biopharma Holdings (NASDAQ:ASBP), H - Benzinga

Apr 15, 2026

Apr 15, 2026

Aspire Biopharma Holdings, Inc. Announces LOI to Acquire Driver Controls Systems Business from Firefish Topco LLC - Minichart

Apr 15, 2026

Apr 15, 2026

Aspire Biopharma's Buzz Bomb Caffeine Company Partners with Interwest Brokerage to Accelerate Retail Expansion - USA Today

Apr 15, 2026

Apr 15, 2026

Buzz Bomb targets Utah, Idaho, Montana stores via Interwest deal - Stock Titan

Apr 15, 2026

Apr 15, 2026

Aspire Biopharma Signs LOI to Acquire DCS Unit - TipRanks

Apr 15, 2026

Apr 15, 2026

Aspire Biopharma signs non-binding letter of intent to acquire DCS unit - Investing.com

Apr 15, 2026

Apr 15, 2026

Aspire Biopharma Signs LOI to Acquire Driver Controls Systems for $30 Million - TradingView — Track All Markets

Apr 15, 2026

Apr 15, 2026

Aspire Biopharma (ASBP) signs non-binding $30M deal for DCS unit - Stock Titan

Apr 15, 2026

Apr 15, 2026

[EFFECT] Aspire Biopharma Holdings, Inc. SEC Filing - Stock Titan

Apr 15, 2026

Apr 14, 2026

Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution - Peoria Journal Star

Apr 14, 2026

Apr 13, 2026

ASPIRE BIOPHARMA HOLDINGS IN (ASBP) Fundamental Analysis & Valuation - ChartMill

Apr 13, 2026

Apr 12, 2026

Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity - Bluffton Today

Apr 12, 2026

Apr 11, 2026

Aspire Biopharma Provides Q3 2025 Business Update - The Augusta Chronicle

Apr 11, 2026

Apr 11, 2026

Aspire Biopharma secures up to $21M in convertible preferred stock financing - MSN

Apr 11, 2026

Apr 10, 2026

159M ASBP (Nasdaq: ASBP) resale shares tied to $20M preferred deal - Stock Titan

Apr 10, 2026

Apr 10, 2026

ASBP Stock Price, Quote & Chart | ASPIRE BIOPHARMA HOLDINGS IN (NASDAQ:ASBP) - ChartMill

Apr 10, 2026

Apr 09, 2026

Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack - Pocono Record

Apr 09, 2026

Apr 08, 2026

Aspire Biopharma Holdings: Innovative Patent-Pending Sublingual Drug Delivery & Product Pipeline Overview - Minichart

Apr 08, 2026

Apr 08, 2026

Aspire Biopharma (NASDAQ: ASBP) details sublingual pipeline and financings - Stock Titan

Apr 08, 2026

Apr 07, 2026

Aspire Biopharma Announces Reverse Stock Split - The Times Telegram

Apr 07, 2026

Apr 04, 2026

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements - Visalia Times-Delta

Apr 04, 2026

Apr 02, 2026

ASBP Technical Analysis | Trend, Signals & Chart Patterns | ASPIRE BIOPHARMA HOLDINGS IN (NASDAQ:ASBP) - ChartMill

Apr 02, 2026

Apr 01, 2026

Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026 - patriotledger.com

Apr 01, 2026

Mar 31, 2026

Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack) - Burlington Free Press

Mar 31, 2026

Mar 31, 2026

Aspire Biopharma: Disruptive Sublingual Drug Delivery Technology, Pipeline, and Patent Portfolio Overview 798289 - Minichart

Mar 31, 2026

Mar 30, 2026

Aspire Biopharma 10-K: Revenue $6.2K, Net Loss $24.48M - TradingView — Track All Markets

Mar 30, 2026

Mar 30, 2026

Reverse recap and sublingual pipeline reshape Aspire Biopharma (NASDAQ: ASBP) - Stock Titan

Mar 30, 2026

Mar 30, 2026

Aspire Biopharma Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 30, 2026

Mar 26, 2026

Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit - The Patriot Ledger

Mar 26, 2026

Mar 25, 2026

ASBP Soars: Biotech Turbulence Fuels an Unexpected 17% Jump - bitget.com

Mar 25, 2026

Mar 24, 2026

Aspire Biopharma's Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director - ACCESS Newswire

Mar 24, 2026

Mar 20, 2026

Aspire Biopharma's Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion - Black Hills Pioneer

Mar 20, 2026

Mar 19, 2026

Aspire Biopharma's Subsidiary Announces Retail Expansion Deal - National Today

Mar 19, 2026

Mar 18, 2026

Aspire Biopharma Plunges 19.5% on Intraday Freefall: What’s Fueling the Sharp Drop? - Bitget

Mar 18, 2026